NCT07098299View on ClinicalTrials.gov

Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 21, 2025

Primary Completion Date

July 7, 2027

Study Completion Date

July 7, 2028

Conditions
Advanced Solid Tumor
Interventions
DRUG

Metformin

Metformin will be given for 14 days alone as a run in and then added to any standard of care chemotherapy or immunotherapy for solid tumors.

All Listed Sponsors
lead

Barbara Ann Karmanos Cancer Institute

OTHER